# Laboratory Validation for Hereditary Tyrosinemia 1 \(HT1\)

> Contract award record from UK public-sector procurement sources.

## Key facts

- Public buyer: [NHS england](/buyers/nhs-england/contract-awards)
- Contract winner: NHS GREATER GLASGOW AND CLYDE
- Award value: £26,523
- Tender value: £26,523
- Award date: 25 March 2024
- Published: 23 April 2024
- Contract start: 1 February 2024
- Contract end: 31 July 2024
- Stage: awarded
- Procurement category: services
- Notice ID: 67eb0867-a8e2-4069-b6d7-b69868a7fd20-743369
- OCID: ocds-b5fd17-11dd918e-85f7-485e-8c89-0172acae95ca

## Description

Stage 1 of Hereditary Tyrosinaemia 1 implementation: Laboratory validation and verification of non-derivatised MSMS kits for use when screening for HT1 using succinylacetone measurement in dried blood spot samples in 3 laboratories\.

## Related contract awards

- [Octopus Deploy Licences](/contracts/ocds-b5fd17-7a50c677-d509-477a-8a8c-7cb6cd368b45): NHS England
- [Transforming & Connecting Care Technology Delivery Service - Enablement Phase](/contracts/ocds-b5fd17-c4e27516-00fe-4409-9b4a-f1a27f7410a0): NHS England
- [NASSTAR T1510 WTE Teams Telephony](/contracts/ocds-b5fd17-1bdf9a7a-14ea-4c0c-be0c-39fd8574a761): NHS England

## Source

[View the original notice on Contracts Finder](https://www.contractsfinder.service.gov.uk/Notice/67eb0867-a8e2-4069-b6d7-b69868a7fd20-743369)